Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report
- PMID: 27707777
- DOI: 10.1136/gutjnl-2016-312288
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report
Abstract
Important progress has been made in the management of Helicobacter pylori infection and in this fifth edition of the Maastricht Consensus Report, key aspects related to the clinical role of H. pylori were re-evaluated in 2015. In the Maastricht V/Florence Consensus Conference, 43 experts from 24 countries examined new data related to H. pylori in five subdivided workshops: (1) Indications/Associations, (2) Diagnosis, (3) Treatment, (4) Prevention/Public Health, (5) H. pylori and the Gastric Microbiota. The results of the individual workshops were presented to a final consensus voting that included all participants. Recommendations are provided on the basis of the best available evidence and relevance to the management of H. pylori infection in the various clinical scenarios.
Keywords: GASTRITIS; HELICOBACTER PYLORI; HELICOBACTER THERAPY.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Comment in
-
Empiric Versus Resistance-Guided Therapy in Obese Patients with Helicobacter Pylori Infection.Obes Surg. 2019 Oct;29(10):3357. doi: 10.1007/s11695-017-3040-8. Obes Surg. 2019. PMID: 31407154 No abstract available.
Similar articles
-
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.Gut. 2012 May;61(5):646-64. doi: 10.1136/gutjnl-2012-302084. Gut. 2012. PMID: 22491499
-
Recent Developments Pertaining to H. pylori Infection.Am J Gastroenterol. 2021 Jan 1;116(1):1-3. doi: 10.14309/ajg.0000000000001031. Am J Gastroenterol. 2021. PMID: 33378314 No abstract available.
-
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015.Dig Liver Dis. 2015 Nov;47(11):903-12. doi: 10.1016/j.dld.2015.06.010. Epub 2015 Jul 6. Dig Liver Dis. 2015. PMID: 26253555
-
Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.Dig Dis Sci. 2020 Jul;65(7):1917-1931. doi: 10.1007/s10620-020-06193-7. Dig Dis Sci. 2020. PMID: 32170476 Review.
-
Adherence to Maastricht V/Florence consensus report for the management of Helicobacter pylori infection among primary care physicians and medical students in Croatia: A cross-sectional study.Helicobacter. 2021 Apr;26(2):e12775. doi: 10.1111/hel.12775. Epub 2020 Dec 23. Helicobacter. 2021. PMID: 33368852
Cited by
-
Testing for Helicobacter pylori in an era of antimicrobial resistance.J Clin Microbiol. 2024 Feb 14;62(2):e0073223. doi: 10.1128/jcm.00732-23. Epub 2024 Jan 9. J Clin Microbiol. 2024. PMID: 38193664 Free PMC article. Review.
-
Alarming antibiotics resistance of Helicobacter pylori from children in Southeast China over 6 years.Sci Rep. 2022 Oct 22;12(1):17754. doi: 10.1038/s41598-022-21661-y. Sci Rep. 2022. PMID: 36272980 Free PMC article.
-
Gastrointestinal cancers: the role of microbiota in carcinogenesis and the role of probiotics and microbiota in anti-cancer therapy efficacy.Cent Eur J Immunol. 2020;45(4):476-487. doi: 10.5114/ceji.2020.103353. Epub 2021 Feb 6. Cent Eur J Immunol. 2020. PMID: 33658894 Free PMC article. Review.
-
Association Between Biofilm Formation and Structure and Antibiotic Resistance in H. pylori.Infect Drug Resist. 2024 Jun 20;17:2501-2512. doi: 10.2147/IDR.S468126. eCollection 2024. Infect Drug Resist. 2024. PMID: 38933776 Free PMC article.
-
Role of Antimicrobial Susceptibility Testing before First-Line Treatment Containing Clarithromycin for Helicobacter pylori Eradication in the Clinical Setting.Antibiotics (Basel). 2021 Feb 21;10(2):214. doi: 10.3390/antibiotics10020214. Antibiotics (Basel). 2021. PMID: 33669969 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical